30 related articles for article (PubMed ID: 10936511)
1. Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis.
Al-Abd AM; Al-Abbasi FA; Nofal SM; Khalifa AE; Williams RO; El-Eraky WI; Nagy AA; Abdel-Naim AB
PLoS One; 2014; 9(11):e111843. PubMed ID: 25375820
[TBL] [Abstract][Full Text] [Related]
2. Low-dose methotrexate results in the selective accumulation of aminoimidazole carboxamide ribotide in an erythroblastoid cell line.
Funk RS; van Haandel L; Becker ML; Leeder JS
J Pharmacol Exp Ther; 2013 Oct; 347(1):154-63. PubMed ID: 23887097
[TBL] [Abstract][Full Text] [Related]
3. Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats.
Yao Y; Ding CZ; Fang Y
Rheumatol Int; 2013 Jul; 33(7):1845-53. PubMed ID: 23334376
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo biological activities of a novel nonpolyglutamable anti-folate, MX-68.
Mihara M; Urakawa K; Takagi N; Moriya Y; Takeda Y
Immunopharmacology; 1996 Oct; 35(1):41-6. PubMed ID: 8913793
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamation of a novel antifolate, MX-68, is not necessary for its anti-arthritic effect.
Urakawa K; Mihara M; Takagi N; Kawamura A; Akamatsu K; Takeda Y
Eur J Pharmacol; 2002 Jan; 435(2-3):237-44. PubMed ID: 11821032
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive properties of MX-68, a novel unpolyglutamatable antifolate.
Mihara M; Suzuki T; Kaneko E; Takagi N; Takeda Y
Biol Pharm Bull; 1997 Oct; 20(10):1071-5. PubMed ID: 9353567
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites.
Gadangi P; Longaker M; Naime D; Levin RI; Recht PA; Montesinos MC; Buckley MT; Carlin G; Cronstein BN
J Immunol; 1996 Mar; 156(5):1937-41. PubMed ID: 8596047
[TBL] [Abstract][Full Text] [Related]
8. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.
Cronstein BN; Naime D; Ostad E
J Clin Invest; 1993 Dec; 92(6):2675-82. PubMed ID: 8254024
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamation of antifolates is not required for induction of extracellular release of adenosine or expression of their anti-inflammatory effects.
Urakawa K; Mihara M; Suzuki T; Kawamura A; Akamatsu K; Takeda Y; Kamatani N
Immunopharmacology; 2000 Jul; 48(2):137-44. PubMed ID: 10936511
[TBL] [Abstract][Full Text] [Related]
10. Characterization by flow cytometry and fluorescein-methotrexate labeling of hydrophilic and lipophilic antifolate resistance in cultured mammalian cells.
Assaraf YG
Anticancer Drugs; 1993 Oct; 4(5):535-44. PubMed ID: 8292810
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells.
Fotoohi AK; Albertioni F
Leuk Lymphoma; 2008 Mar; 49(3):410-26. PubMed ID: 18297517
[TBL] [Abstract][Full Text] [Related]
12. Antifolate analogs: mechanism of action, analytical methodology, and clinical efficacy.
Fleisher M
Ther Drug Monit; 1993 Dec; 15(6):521-6. PubMed ID: 8122287
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
